Skip to content

Sex influence on cancer incidence after a cardiovascular event: a population study

Aug 2026 · European Heart Journal, Supplement · Vol 28 · 0 citations

TL;DR

Patients with newly diagnosed CVD present a higher risk of cancer when compared to patients without a history of prior CVD, and men show a higher risk of incident cancer over time when patients with CVD are subclassified by biological sex, when patients with CVD are subclassified by biological sex.

Abstract

Cardiovascular disease (CVD) and cancer share common risk factors and pathophysiological pathways. Previous studies have shown that patients with prevalent CVD present an increased risk of developing cancer in the future. Nevertheless, the effect of biological sex on cancer incidence after a recent cardiovascular event remains largely unexplored. To analyze the influence of biological sex on mid-long term incidence of cancer in patients with a new diagnosis of CVD. To evaluate the impact of sex on cancer outcomes according to the concrete type of cardiovascular event. We performed a retrospective population-based cohort study using data from 2010-2022 clinical and administrative databases from our healthcare area. All adults (>18 years) without a prior history of cancer or CVD at first medical contact were included. During a run-in period of 24 months, patients with a new diagnosis of cancer or CVD were excluded. After this initial timeline, patients were classified into 2 groups in a dynamic manner depending on the presence or absence of new CVD, as defined by International Classification of Disease (ICD) 9th and 10th editions. The primary outcome of interest was incident cancer, also ascertained by means of ICD codes after the 24-month run-in period. Nonmelanoma skin cancers were not included. Statistical analysis comprised cox proportional hazards models adjusted for age, diabetes, hypertension, dyslipidemia and smoking. A total of 238,415 adults were included, of whom 52.20% were women. Compared to men, women were older (45.9 vs 43.7 years, p<0.01) and had a higher prevalence of anemia (10.73 vs 45.8%, p<0.01= and depression (5.48% vs 2.40%, p<0.01), whilst men presented a greater history of alcohol abuse (5.75% vs 1.15%, p<0.01) and chronic obstructive pulmonary disease (5.92% vs 3.14%, p<0.01). When compared to patients without a prior history of CVD, patients with a new diagnosis of CVD showed an increased risk of incident cancer over time, with and adjusted hazard ratio (HR) of 1.56 (95%CI 1.47-1.67) (picture 1). When stratified by biological sex, cancer incidence was similar between males and females without prior CVD. Nevertheless, in the subgroup of patients with a new diagnosis of CVD, men exhibited a higher risk of cancer over time compared to women (HR 1.13; 95%CI 1.08-1.18; picture 2). Regarding type of CVD, men showed a higher risk of incident cancer in relation to women when the cardiovascular event was heart failure, coronary heart disease or cerebrovascular disease, but not in the case of atrial fibrillation. Patients with newly diagnosed CVD present a higher risk of cancer when compared to patients without a history of prior CVD. When patients with CVD are subclassified by biological sex, men show a higher risk of incident cancer over time.Cancer Incidence Stratified by Presence  Cancer Incidence Stratified by Sex and P

View source

Similar papers

Aug 2026

Five-year cancer incidence after new cardiovascular disease: a population study

In this population-based cohort study, the five-year incidence of cancer following a new diagnosis of CVD was markedly high and the distribution of cancer types in this population differed from that of the general population, with a higher proportion of genitourinary cancers and a lower proportion of breast cancer.

P. Moliner, H. Morillas, A. Ricarte-Marin et al. · 0 citations
Open access Aug 2026

Sex differences in cancer incidence and mortality in patients with cardiovascular disease: the European Prospective Investigation into Cancer-Norfolk study.

BACKGROUND AND AIMS The incidence of cancer in people with cardiovascular disease (CVD) is poorly understood. This study aimed to understand the sex differences in incident cancer and cancer-related mortality in people with and without CVD. METHODS Participants were drawn from the European Prospective Investigation i...

R. Thuemmler, T. Pana, M. Mamas et al. · 0 citations
Review Aug 2026

Impact of cardiovascular disease on cancer incidence and mortality

– Emerging evidence has revealed that cardiovascular diseases (CVDs) identify individuals prone to developing cancer. However, the precise impact and which CVD is most associated with future cancer is not clear. Therefore, we present an up-to-date impact of CVD on cancer incidence and cancer-related mortality....

L. Yousif, P. Ameri, M. Vinci et al. · 0 citations
Aug 2026

Cardiovascular disease in breast cancer patients receiving chemotherapy: epidemiology and risk factors

Evaluating the occurrence of new-onset CVD in women with breast cancer undergoing chemotherapy and identifying factors associated with increased risk of cardiovascular disease highlights the need for sustained cardiovascular surveillance in breast cancer survivors.

V. Dvorovy, L. Kováčová, M. Selvek et al. · 0 citations
Aug 2026

Pre-existing cardiovascular disease at cancer diagnosis: national trends and future projections in england

The burden of pre-existing CVD at cancer diagnosis has increased substantially over the past two decades in the UK and is projected to rise further, highlighting the growing need for integrated prevention strategies and cardio-oncology services to address increasing multimorbidity in patients with cancer.

A. Alshahrani, E. Kontopantelis, C. Morgan et al. · 0 citations
Open access Aug 2026

Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England.

BACKGROUND AND AIMS Advances in cancer care have improved survival, increasing the importance of comorbidities at diagnosis for longer-term outcomes. Pre-existing cardiovascular disease (CVD) can complicate management and prognosis, yet its long-term trends and future burden at cancer diagnosis are unclear. This study...

A. Alshahrani, E. Kontopantelis, C. Morgan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.